https://nucleai.boldfocus.com/nucleai-advances-ai-powered-tissue-intelligence-through-large-scale-oncology-adc-collaboration/ 2026-08-11T02:16:29+00:00 https://nucleai.boldfocus.com/nucleai-expands-its-strategic-partnership-with-university-of-glasgow-to-advance-access-to-its-multimodal-tissue-intelligence-ai-platform/ 2026-07-16T13:43:46+00:00 https://nucleai.boldfocus.com/nucleai-and-sirona-dx-partner-to-deliver-an-integrated-spatial-proteomics-solution-for-pharma-drug-development/ 2026-04-15T13:13:59+00:00 https://nucleai.boldfocus.com/nucleai-to-showcase-expanded-suite-of-adc-biomarker-scoring-solutions-at-asco-2025/ 2026-04-15T13:13:21+00:00 https://nucleai.boldfocus.com/investment-report-interview-with-avi-veidman/ 2026-01-18T17:30:23+00:00 https://nucleai.boldfocus.com/ai-powered-spatial-biology-workflow-from-bio-techne-and-nucleai-enables-predictive-biomarker-discovery-in-melanoma-patients/ 2025-11-13T18:40:34+00:00 https://nucleai.boldfocus.com/nucleai-and-university-of-glasgow-partner-to-pioneer-multimodal-precision-medicine-for-colorectal-cancer/ 2025-11-13T18:35:05+00:00 https://nucleai.boldfocus.com/top-10-spatial-biology-companies-of-2025/ 2025-11-12T20:26:01+00:00 https://nucleai.boldfocus.com/beyond-cell-atlases-spatial-biology-reveals-mechanisms-behind-disease/ 2025-05-23T19:43:20+00:00 https://nucleai.boldfocus.com/nucleai-launches-first-of-its-kind-deep-learning-model-to-automate-spatial-proteomics-accelerating-biomarker-discovery-for-adcs-bispecifics-and-immunotherapy/ 2025-04-22T13:30:35+00:00 https://nucleai.boldfocus.com/how-ai-and-spatial-biomarkers-are-transforming-antibody-drug-conjugate-development/ 2025-03-27T00:31:15+00:00 https://nucleai.boldfocus.com/nucleai-hopes-to-engage-pharma-on-next-gen-immunotherapies-with-proof-of-concept-ai-based-biomarker/ 2024-11-05T16:12:40+00:00 https://nucleai.boldfocus.com/nucleai-launches-new-multiplex-imaging-spatial-analysis-solution-to-increase-reliability-and-speed-of-immunofluorescence-analysis-for-drug-discovery-and-development/ 2024-11-05T16:09:16+00:00 https://nucleai.boldfocus.com/nucleai-and-adlai-nortye-partner-to-identify-and-validate-novel-spatial-biomarkers-across-adlai-clinical-trials/ 2024-11-05T16:08:14+00:00 https://nucleai.boldfocus.com/nucleai-and-mayo-clinic-biopharma-diagnostics-announce-strategic-collaboration-to-transform-digital-pathology-for-drug-development-and-clinical-practice/ 2024-11-05T16:05:10+00:00 https://nucleai.boldfocus.com/mercks-corporate-venture-m-ventures-arm-backs-nucleai-to-advance-its-first-in-class-spatial-ai-biomarker-in-active-clinical-enrollment/ 2024-11-05T16:03:23+00:00 https://nucleai.boldfocus.com/nucleai-unveils-breakthrough-ai-spatial-biomarker-advancements-at-aacr-2024-with-the-potential-to-transform-cancer-diagnostics-and-treatments/ 2024-11-05T15:51:35+00:00 https://nucleai.boldfocus.com/nucleai-and-gopath-diagnostics-announce-strategic-collaboration-to-provide-integrated-ai-powered-digital-pathology-solutions-for-clinical-research-and-diagnostic-applications/ 2024-11-05T15:49:53+00:00 https://nucleai.boldfocus.com/proscia-and-nucleai-partner-to-broaden-access-to-ai-predictive-biomarkers/ 2024-11-05T15:48:01+00:00 https://nucleai.boldfocus.com/how-ai-startups-working-on-clinical-trials-for-cancer-could-find-a-breakthrough-before-big-pharma/ 2024-11-05T15:46:26+00:00 https://nucleai.boldfocus.com/how-nucleais-spatial-biology-tech-aims-to-accelerate-drug-development/ 2024-11-05T15:45:42+00:00 https://nucleai.boldfocus.com/top-10-spatial-biology-companies-of-2024/ 2024-11-05T15:42:14+00:00 https://nucleai.boldfocus.com/research-shows-pathway-to-developing-predictive-biomarkers-for-immune-checkpoint-inhibitors/ 2024-11-05T15:41:28+00:00 https://nucleai.boldfocus.com/how-spatial-ai-is-uncovering-the-hidden-truths-of-breast-cancer/ 2024-11-05T15:36:21+00:00 https://nucleai.boldfocus.com/targeting-the-blast-radius-why-spatial-ai-diagnostics-are-crucial-for-maximizing-the-impact-of-antibody-drug-conjugates/ 2024-11-05T15:33:32+00:00 https://nucleai.boldfocus.com/nucleai-highlights-ai-powered-spatial-biomarker-breakthroughs-to-enhance-immunotherapy-success-for-lung-and-skin-cancer-patients-at-sitc-2024/ 2024-11-05T15:05:15+00:00 https://nucleai.boldfocus.com/50-companies-igniting-chicagos-startup-scene-in-2024/ 2024-06-29T03:13:49+00:00 https://nucleai.boldfocus.com/nucleai-appoints-vikas-ahuja-as-vice-president-of-strategic-partnerships-to-enable-diagnostic-deployment-and-commercialization-at-scale/ 2024-05-16T12:14:26+00:00 https://nucleai.boldfocus.com/nucleai-expands-scientific-advisory-board-with-oncology-industry-luminary-dr-julian-adams/ 2023-09-11T14:12:09+00:00 https://nucleai.boldfocus.com/nucleai-appoints-new-head-of-pathology-to-support-expansion-in-biopharmaceutical-and-clinical-markets/ 2023-09-11T14:11:37+00:00 https://nucleai.boldfocus.com/lunaphore-and-nucleai-announce-a-partnership-to-provide-ai-powered-spatial-biology-analysis-to-accelerate-drug-development/ 2023-09-11T14:10:59+00:00 https://nucleai.boldfocus.com/nucleai-expands-leadership-team-and-scientific-advisory-board-with-pharmaceutical-industry-experts/ 2023-05-24T19:41:08+00:00 https://nucleai.boldfocus.com/spatial-multiomics-powers-pathology-prediction/ 2023-01-12T15:26:39+00:00 https://nucleai.boldfocus.com/israel-an-untapped-biotech-investment-opportunity/ 2022-10-24T17:04:44+00:00 https://nucleai.boldfocus.com/nucleai-propath-partnership-spatial-oncology-biomarkers/ 2022-09-29T17:29:05+00:00 https://nucleai.boldfocus.com/nucleai-and-propath-uk-announce-partnership-for-end-to-end-ai-powered-spatial-analysis-of-a-30-plex-immunofluorescence-immuno-oncology-panel/ 2022-09-22T05:28:12+00:00 https://nucleai.boldfocus.com/how-ai-helps-advance-immunotherapy-and-precision-medicine/ 2022-09-08T09:32:47+00:00 https://nucleai.boldfocus.com/how-ai-helps-advance-immunotherapy-and-precision-medicine/ 2022-09-07T18:30:08+00:00 https://nucleai.boldfocus.com/nucleai-and-jefferson-health-launch-a-strategic-collaboration-to-discover-novel-spatial-immunotherapy-biomarkers-utilizing-nucleais-spatial-biology-platform-2/ 2022-09-07T18:23:03+00:00 https://nucleai.boldfocus.com/nucleai-and-jefferson-health-launch-a-strategic-collaboration-to-discover-novel-spatial-immunotherapy-biomarkers-utilizing-nucleais-spatial-biology-platform-3/ 2022-09-07T18:21:17+00:00 https://nucleai.boldfocus.com/nucleai-series-b-financing/ 2022-09-07T18:20:00+00:00 https://nucleai.boldfocus.com/nucleai-to-publish-pathology-based-data-at-asco-2022-for-phase-2-research-of-the-most-common-type-of-non-hodgkins-lymphoma-newsw/ 2022-09-07T16:37:28+00:00 https://nucleai.boldfocus.com/nucleai-announces-partnership-ultivue/ 2022-09-07T16:36:13+00:00 https://nucleai.boldfocus.com/nucleai-announces-new-data-showing-better-prediction-of-response-to-immune-checkpoint-inhibitors-for-nsclc-patients/ 2022-09-07T16:31:14+00:00 https://nucleai.boldfocus.com/nucleai-and-merck-kgaa-darmstadt-germany-launch-translational-medicine-collaboration-utilizing-nucleais-ai-powered-biomarker-platform/ 2022-03-16T09:54:53+00:00